Show simple item record

dc.contributor.authorRussell, N.
dc.contributor.authorHills, R.
dc.contributor.authorKjeldsen, L.
dc.contributor.authorDennis, Michael
dc.contributor.authorBurnett, A.
dc.date.accessioned2022-01-11T12:00:16Z
dc.date.available2022-01-11T12:00:16Z
dc.date.issued2021en
dc.identifier.citationRussell N, Hills R, Kjeldsen L, Dennis M, Burnett A. Treatment intensification with FLAG‐Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long‐term follow up of the MRC AML15 trial British Journal of Haematology. Wiley; 2021.en
dc.identifier.pmid34904225en
dc.identifier.doi10.1111/bjh.17974en
dc.identifier.urihttp://hdl.handle.net/10541/624988
dc.titleTreatment intensification with FLAG-Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long-term follow up of the MRC AML15 trialen
dc.typeOtheren
dc.contributor.departmentDepartment of Haematology, Guy's Hospital, London, UKen
dc.identifier.journalBritish Journal of Haematologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record